Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,385,866 papers from all fields of science
Search
Sign In
Create Free Account
Efflumidex
Known as:
Pharm Allergan Brand of Fluorometholone
, Pharm-Allergan Brand of Fluorometholone
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Fluorometholone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Extracranial Injections of OnabotulinumtoxinA in Combination with Intravenous Injection of Atogepant Attenuates Activation and Sensitization of HT and WDR Neurons by CSD (4287)
A. Melo-Carrillo
,
A. Strassman
,
Aaron J. Schain
,
A. Adams
,
M. Brin
,
R. Burstein
Neurology
2020
Corpus ID: 219786263
Objective: To determine the effects of a combination therapy with BoNT-A and atogepant (Ato) on the responsiveness of central…
Expand
2018
2018
Evaluation of Eluxadoline Effect on Cardiac Repolarization
L. Bonifacio
,
T. Hunt
,
G. McIntyre
,
L. S. Dove
,
P. Covington
Clinical pharmacology in drug development
2018
Corpus ID: 4972695
This study evaluated the effects of eluxadoline, a mixed μ‐opioid receptor (OR) and κ‐OR agonist and δ‐OR antagonist, on cardiac…
Expand
2017
2017
Low Incidence of Clean Intermittent Catheterisation With OnabotulinumtoxinA in Diverse Age Groups of Overactive Bladder Patients With Corresponding Improvements in Urinary Symptoms, Treatment…
V. Nitti
,
M. Drake
,
+7 authors
C. Chapple
2017
Corpus ID: 79497486
Nitti V1, Drake M2, Everaert K3, Rovner E4, Dmochowski R5, Ginsberg D6, Radomski S7, Aboushwareb T8, Chang C9, Chapple C10 1. New…
Expand
2016
2016
OC-070 Eluxadoline Demonstrates Efficacy for the Treatment of Irritable Bowel Syndrome (IBS) with Diarrhoea (IBS-D) Among Multiple Clinically Relevant Patient Subgroups
B. Lacy
,
W. Chey
,
A. Lembo
,
LS Dove
,
PS Covington
2016
Corpus ID: 78680623
Introduction Eluxadoline (ELX) is a mixed µ- and κ-opioid receptor (OR) agonist and δ-OR antagonist. It is locally active and…
Expand
Review
2015
Review
2015
[Poly Implant Prothèse (PIP®) incidence of complications in breast reconstructive surgery: A retrospective comparative analysis].
C. Fenoll
,
Franck Marie Leclère
,
+4 authors
P. L. Masurier
Annales de Chirurgie Plastique et Esthétique
2015
Corpus ID: 40600512
2015
2015
Quantitative Analysis of Ambroxol Hydrochloride and Loratadine in Bulk and Pharmaceutical Formulations
P. Arumugam
2015
Corpus ID: 105551587
INTRODUCTION: Everything made by human hands is subject to decay. Pharmaceuticals are no exception to this. A drug for oral use…
Expand
2008
2008
Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids
K. Boulle
2008
Corpus ID: 5276838
Background: The clinical characteristics of botulinum toxin type A (BoNTA) depend on the formulation used. Objective: To evaluate…
Expand
2007
2007
[Comparison of posterior capsule opacification in 2 types of implanted artificial intraocular lens].
J. Pozlerová
,
J. Nekolova
,
N. Jiraskova
,
J. Kadlecová
,
P. Rozsival
Czech and Slovak Ophthalmology
2007
Corpus ID: 31094715
PURPOSE To compare posterior capsule opacification (PCO) incidence and the best corrected visual acuity (BCVA) in patients who…
Expand
2004
2004
Klinisch-toxikologische Zusammenstellung der Vergiftungsfälle in Florenz im Triennium 1950–1952
Giuliano Abbozzo
Fühner-Wieland's Sammlung von Vergiftungsfällen
2004
Corpus ID: 40929787
u. E. Jacobsen: Acta pharm, et tox. 4, 305 (1948); Lancet II, 1001 (1948). Hald, J. u. V. Larsen: Acta pharm, et tox. 8, 292…
Expand
1992
1992
Comparative evaluation of the Allergan Humphrey 570 and Canon RK-l autorefractors: I. Objective autorefraction in normal subjects
P. S. Raj
,
J. Villada
,
A. E. Lewis
,
P. W. Joyce
,
A. Watson
Eye
1992
Corpus ID: 29447847
Fifty normal subjects were studied comparing objective autorefraction using the Allergan Uumphrey 570 (AU 570) and Canon RK-1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE